Cargando…

COVID-19—a very visible pandemic – Author's reply

Detalles Bibliográficos
Autor principal:	Giesecke, Johan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832477/ https://www.ncbi.nlm.nih.gov/pubmed/32771115 http://dx.doi.org/10.1016/S0140-6736(20)31677-9

Ejemplares similares

COVID-19—a very visible pandemic
por: Lindahl, Johanna F, et al.
Publicado: (2020)

COVID-19—a very visible pandemic
por: Ramachandran, Raja
Publicado: (2020)

COVID-19—a very visible pandemic
por: Ewing, Andrew
Publicado: (2020)

COVID-19—a very visible pandemic
por: Keil, Evan J
Publicado: (2020)

COVID-19—a very visible pandemic
por: Durrheim, David N, et al.
Publicado: (2020)

COVID-19—a very visible pandemic
por: King, Carina, et al.
Publicado: (2020)

Surgery during the COVID-19 pandemic – Authors' reply
por: COVIDSurg Collaborative
Publicado: (2020)

Undermining breastfeeding will not alleviate the COVID-19 pandemic – Authors' reply
por: Groß, Rüdiger, et al.
Publicado: (2020)

Cancer and COVID-19 – Authors' reply
por: Kuderer, Nicole M, et al.
Publicado: (2020)

Remdesivir and COVID-19 – Authors' reply
por: Wang, Yeming, et al.
Publicado: (2020)

Head and neck surgery recommendations during the COVID-19 pandemic – Author's reply
por: Mehanna, Hisham
Publicado: (2020)

Bariatric and metabolic surgery during and after the COVID-19 pandemic – Authors' reply
por: Cummings, David E, et al.
Publicado: (2020)

Models for mortality require tailoring in the context of the COVID-19 pandemic – Authors' reply
por: Banerjee, Amitava, et al.
Publicado: (2020)

Effect of anakinra in COVID-19 – Authors' reply
por: Cavalli, Giulio, et al.
Publicado: (2020)

COVID-19 in patients with HIV – Authors' reply
por: Miró, José M, et al.
Publicado: (2020)

Mavrilimumab for severe COVID-19 – Authors' reply
por: De Luca, Giacomo, et al.
Publicado: (2020)

COVID-19 and preterm birth – Authors' reply
por: Choudhary, Rahul, et al.
Publicado: (2021)

Neuropsychiatric disorders and COVID-19 – Authors' reply
por: Taquet, Maxime, et al.
Publicado: (2021)

COVID-19 and myocardial infarction – Authors' reply
por: Katsoularis, Ioannis, et al.
Publicado: (2021)

Fluvoxamine for the treatment of COVID-19 – Author's reply
por: Reis, Gilmar, et al.
Publicado: (2022)

COVID-19 research in LMICs – Authors' reply
por: Torres, Irene, et al.
Publicado: (2021)

Asymptomatic health-care worker screening during the COVID-19 pandemic – Authors' reply
por: Treibel, Thomas A, et al.
Publicado: (2020)

Frailty and mortality in patients with COVID-19 – Authors' reply
por: McCarthy, Kathryn, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia – Authors' reply
por: Guaraldi, Giovanni, et al.
Publicado: (2020)

Anakinra for severe forms of COVID-19 – Authors' reply
por: Hayem, Gilles, et al.
Publicado: (2020)

Psychiatric and neuropsychiatric syndromes and COVID-19 – Authors' reply
por: Rogers, Jonathan P, et al.
Publicado: (2020)

Management of diabetes in patients with COVID-19 – Authors' reply
por: Bornstein, Stefan R, et al.
Publicado: (2020)

COVID-19: from hospitals to courts – Author's reply
por: Usuelli, Michele
Publicado: (2021)

Azithromycin for mild-to-moderate COVID-19 – Authors' reply
por: Hinks, Timothy S C
Publicado: (2021)

Antipsychotics and COVID-19: the debate goes on – Authors' reply
por: De Picker, Livia, et al.
Publicado: (2021)

Depression and anxiety during COVID-19 – Authors' reply
por: Santomauro, Damian F, et al.
Publicado: (2022)

WHO COVID-19 therapeutic guidelines – Authors' reply
por: White, Nicholas J, et al.
Publicado: (2021)

COVID-19 and global mental health – Authors' reply
por: Kola, Lola, et al.
Publicado: (2021)

COVID-19 and maternal and perinatal outcomes – Authors' reply
por: Chmielewska, Barbara, et al.
Publicado: (2021)

Combining immunomodulators and antivirals for COVID-19 – Authors' reply
por: Almansa, Raquel, et al.
Publicado: (2021)

Barriers to hospital electronic public health reporting and implications for the COVID-19 pandemic: the authors’ reply
por: Holmgren, A Jay, et al.
Publicado: (2020)

Authors’ reply
por: Gibbons, Rachel, et al.
Publicado: (2020)

Authors' reply
por: Baud, David, et al.
Publicado: (2020)

Authors’ Reply
por: Kumar, Jogender
Publicado: (2020)

Reply to Authors
por: Banna, Giuseppe, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_trkup1ivh04g4lr42d17ku8n6l